Myasthenia gravis.
Barboi
A C
AC
Department of Neurological Sciences, Section of Neuromuscular Diseases, Rush Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.
Meriggioli
M N
MN
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D013934:Thymectomy
D000305:Adrenal Cortex Hormones; D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents